Taiwan Liposome reaches full enrollment for arthritis candidate PhI/II trial.

ASLAN notches second FDA orphan designation for ASLAN001

The opioid abuse epidemic is a thicket of particular issues. But one of the challenges of adopting alternative painkillers is more common: Price.

Drugmakers haven’t much cared for a Boston-based nonprofit’s cost-effectiveness assessments of their drugs. And now, they’re going on the offensive.

​Dealing a blow to AstraZeneca in its largest FluMist Quadrivalent market, a CDC committee has stiff-armed the nasal vaccine for the upcoming season. Why? The…

Biocon and RNAi firm Quark Pharmaceuticals said the first patient has received a randomized dose in a clinical trial for ocular neuroprotection siRNA (small…

Now that Sanofi’s hostile Medivation quest has begun, the pharma giant is wondering whether it can sway investors by tossing in future payments.

Costa Rica nod the fifth approval for Sanofi's Dengvaxia

Fujifim has licensed the active pharmaceutical ingredient for flu drug Avigan to Zhejiang Hisun Pharmaceuticals.